Ikarovec is a UK-based, pre-clinical/near-clinical stage biotechnology company developing novel bi-functional gene therapies for vision-threatening retinal diseases, particularly Age-Related Macular Degeneration (AMD). The company does internal R&D and partners with CDMOs like Rentschler Biopharma for manufacturing scale-up. It is not a contract manufacturer itself.
gene therapy for ophthalmology, bi-functional gene therapies, retinal disease treatment, AMD therapeutics
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.